CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome
Completed · Phase 2
Conditions studied: BCCs in Gorlin Syndrome Patients
In brief
A Phase 2b study looks at the safety and efficacy of a treatment that is being investigated for people with certain diseases. This study will be conducted at multiple centers in the United States where participants with Gorlin Syndrome, also known as basal cell nevus syndrome, will be randomly placed into two groups; one group will receive the active topical gel, the other a topical vehicle gel, also know as placebo. Participants will apply this topical product to their face once a day for 6 months. The study will be looking at the number of new BCCs that develop on the faces of all the participants during this time.
Key facts
- Study ID
- NCT04893486
- Run by
- Palvella Therapeutics, Inc.
- People needed
- 73
- Starts
- 2021-05-06
- Expected to finish
- 2023-03-13
- Last updated by the study team
- 2024-08-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic — Scottsdale, Arizona, United States
- Burke Pharmaceuticals Research — Hot Springs, Arkansas, United States
- Stanford Univeristy — Palo Alto, California, United States
- Park Avenue Dermatology — Orange Park, Florida, United States
- Ameriderm Research — Ormond Beach, Florida, United States
- Gwinett Clinical Research Center — Snellville, Georgia, United States
- Clinical Coordinating Center (Minnesota) — New Brighton, Minnesota, United States
- Mayo Clinic - Minnesota — Rochester, Minnesota, United States
- St. Louis University — St Louis, Missouri, United States
- Duke University — Durham, North Carolina, United States
- Penn State Hershey Medical Center — Hershey, Pennsylvania, United States
- DermResearch Inc — Austin, Texas, United States
- University of Utah — Murray, Utah, United States
- Virginia Clinical Research, Inc. — Norfolk, Virginia, United States
- St. Pancras Clinical Research — London, United Kingdom
- Salford Foundation Trust — Salford, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.